NCT05826535 2026-02-24Study of LYL314 in Aggressive Large B-Cell LymphomaLyell Immunopharma, Inc.Phase 1/2 Recruiting270 enrolled
NCT03016377 2025-10-27Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALLUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Active not recruiting17 enrolled
NCT03743246 2024-08-15A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)CelgenePhase 1/2 Terminated21 enrolled 33 charts
NCT02134262 2014-11-06Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesJichi Medical UniversityPhase 1/2 Unknown18 enrolled